It is a sad fact that there are a lot of medications and treatments that are first considered to be safe and effective but they are later proven to harm the body.
Although this happens in rare circumstances, it is real.
Diethylstilbestrol is one of the verification that these things do occur.
In the late 1930's before the world war two, there is a production of man made estrogen hormones.
This is often referred to as DES.
When the diethylstilbestrol was first sold in the market, it was used for different condition.
The most common one is where there is a need for hormone replacement.
The first use of diethylstilbestrol was for women with menopausal problems.
These are often treated with hormone replacement therapies.
Other cases involve atrophic vaginitis.
There are cases where doctors found this diethylstilbestrol to have positive benefits for those men who want to treat prostrate cancer.
This is also used for women who have a high risk of pregnancy.
There are studies that were done that showed that diethylstilbestrol can prove to be carcinogen.
It is not recommended for pregnant women because there are studies that prove that if the mother take this; there is a chance that the child can develop cancer in the vagina.
Another negative effect of this diethylstilbestrol is the fact that it can cause birth defects if the mother is taking the drug during pregnancy.
Despite the potential risk, the DES remains to be sold in the market.
Because men don't get pregnant, they are the ones who are likely to choose this hormone.
In 1990's this diethylstilbestrol was banned in the market.
Currently, there are no companies that are making this estrogen hormone.
It was said that there are millions of people that induced the diethylstilbestrol while it was in the market.
Although there are none sold in America, there are third world countries that uses.
This is something that doctors tend to consider.
The story of DES is rather sad.
The process of review took sometime before they are released in the market.
These medications are not used for pregnant women until further studies.
There are corrections in the drug approval process after the DES incident.
Hopefully this story should serve as a warning for people who are trying to sell drugs in the market.
It is best that consumers should be careful when they take in new drugs.
Although this happens in rare circumstances, it is real.
Diethylstilbestrol is one of the verification that these things do occur.
In the late 1930's before the world war two, there is a production of man made estrogen hormones.
This is often referred to as DES.
When the diethylstilbestrol was first sold in the market, it was used for different condition.
The most common one is where there is a need for hormone replacement.
The first use of diethylstilbestrol was for women with menopausal problems.
These are often treated with hormone replacement therapies.
Other cases involve atrophic vaginitis.
There are cases where doctors found this diethylstilbestrol to have positive benefits for those men who want to treat prostrate cancer.
This is also used for women who have a high risk of pregnancy.
There are studies that were done that showed that diethylstilbestrol can prove to be carcinogen.
It is not recommended for pregnant women because there are studies that prove that if the mother take this; there is a chance that the child can develop cancer in the vagina.
Another negative effect of this diethylstilbestrol is the fact that it can cause birth defects if the mother is taking the drug during pregnancy.
Despite the potential risk, the DES remains to be sold in the market.
Because men don't get pregnant, they are the ones who are likely to choose this hormone.
In 1990's this diethylstilbestrol was banned in the market.
Currently, there are no companies that are making this estrogen hormone.
It was said that there are millions of people that induced the diethylstilbestrol while it was in the market.
Although there are none sold in America, there are third world countries that uses.
This is something that doctors tend to consider.
The story of DES is rather sad.
The process of review took sometime before they are released in the market.
These medications are not used for pregnant women until further studies.
There are corrections in the drug approval process after the DES incident.
Hopefully this story should serve as a warning for people who are trying to sell drugs in the market.
It is best that consumers should be careful when they take in new drugs.